The Chinese Pharma industry is rapidly upgrading its capabilities, moving from being a supplier of basic molecules and generics to becoming a major force in the development of innovative, molecular-targeted treatments and gene-based therapies. The Swiss Chinese Life Sciences Forum 2018 organised by BaselArea.swiss, the Fachhochschule Nordwestschweiz and the Swiss Chinese Chamber of Commerce and hosted by Novartis offers insights into key players in the Chinese Pharma landscape and identifies opportunities for greater collaboration between Swiss and Chinese Pharma.


Key themes:

  • Innovation in the Chinese Pharma Industry
  • Internationalisation – Chinese Pharma companies go global
  • China’s recent regulatory reform and the impact on innovation
  • Swiss Pharma in China – the case of Novartis
  • Collaboration between European and Chinese Life Sciences companies


For details and registration visit www.swiss-chinese-life-sciences-forum.ch


Programm Details

13:30
Welcome Addresses
arrow

  • Matthias Leuenberger, Country President Switzerland, Novartis
  • Thomas Christ, Acting President SCCC

13:45
Novartis Shanghai Campus Live Transmission
arrow

Live Stream

Dr. Larry Zhang, VP, Head Public Affairs & CSR, Novartis China

14:05
Keynote 1 – "Challenges and opportunities of creating a global pharmaceutical company in China."
arrow
John Oyler, CEO and Founder of BeiGene
14:25
Keynote 2 – "Luye Pharma Group’s Internationalization: Strategy and Experiences."
arrow
Sammy Jiang, VP Luye Pharma Group
14:45
Keynote 3 – "Regulatory reform in China: How to rapidly bring innovative drugs to market."
arrow
Dr. Ruyi He, Chief Scientist at the Center for Drug Evaluation at the China Food and Drug Administration (CFDA)
15:30
Keynote 4 - "Going East – China as the frontier for new Innovation"
arrow
Nigel Sheail, Global Head M&A and BD&L, Novartis International AG
15:50
Keynote 5 – Swiss-Chinese Pharma Deal: Challenges and Learnings
arrow
Martin Rohrbach, Partner, Head of Life Sciences, KPMG Switzerland
16:10
Panel discussion
arrow
Keynote speakers + Michael Frizberg, CEO, CMAB International
17:00
Closing summary & thanks
17:10
Apéro
18:30
End
*SOLD OUT* Swiss-Chinese Life Sciences Forum “Chinese Pharma Goes Global”
九月 13, 2018
13:30-18:30
Novartis Campus, Fabrikstrasse 2, 4056 Basel
更多。。。
附加信息

Registration on first come, first serve basis.

Register here

The Organisors:

Host:

Event Sponsors: